The Pharmacist's Role in Transitioning Patients from Infusion to Oral Chemotherapy


Julianne Orr, PharmD, from the Indiana University Health Simon Cancer Center, discusses how pharmacists can help patients who are transitioning from an infusion product to an oral chemotherapy.

"If they're transitioning from an infusion product, typically their physician hasn't changed. Usually we kind of count on the physician and the clinical team in the cancer center to navigate that process and then my role and my team comes in when the oral chemotherapy is prescribed. They've been on an infusion product before, so that kind of helps us give us an idea of how they handled that treatment, what kind of side effects they had, what sort of things I need to be cognizant of going into that treatment with an oral treatment, and navigating their understanding of the differences between and IV product and an oral product. And then, as a pharmacist, hitting home with adherence and making sure they're staying on these medications and taking them the way that they should is a key component of transitioning. Understanding that no one is going to be checking in on them on a daily basis, so they need to understand how to take these drugs and take them as prescribed."

Most Popular

Related Articles

The approval of ivosidenib fills an unmet need for patients with relapsed or refractory acute myeloid leukemia who have an IDH1 genetic mutation.
Gene-editing technology could lead to new targeted therapies and help clinicians catch developing cancers before they metastasize.
Genentech announced that the FDA has granted Breakthrough Therapy Designation to atezolizumab (Tecentriq) in combination with bevacizumab (Avastin) as a first-line treatment for patients with the most common form of liver cancer.
Company Profile >
Contributors >
Industry Guide >
Market News >
Peer Exchange >
Conferences >
Subscribe >
Specialty Times Resources
About Us
Advertise
Careers
Contact Us
Terms & Conditions
Privacy
MJH Associates >
Pharmacy Times
OTCGuide
American Journal of Managed Care
Cure
MD Magazine
ONCLive
Targeted Oncology
Physicians' Education Resource
Pharmacy & Healthcare Communications, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright Specialty Pharmacy Times 2006-2018
Pharmacy & Healthcare Communications, LLC. All Rights Reserved.
 

$vacMongoViewPlus$